IceCure Medical (ICCM) Income towards Parent Company (2025 - 2026)

IceCure Medical (ICCM) reported Income towards Parent Company of $4.2 million for Q1 2026, up 16.13% year-over-year from $3.7 million in Q1 2025, and up 16.13% on a QoQ basis from $3.7 million in Q1 2025.

IceCure Medical (ICCM) has 2 years of Income towards Parent Company data on file, last reported at $4.2 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 16.13% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (up 116.13% YoY) and the FY2025 annual result came in at -$15.1 million, up 3.84% from the prior year.
  • Income towards Parent Company grew to $4.2 million in Q1 2026 per ICCM's latest filing, from $3.7 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $4.2 million in Q1 2026 and bottomed at $3.7 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 IceCure Medical 12.09 -8.11 Mn 295,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.25 Mn
Mar 31, 2025 3.66 Mn